Evidence map›Paper›PMID 26739494›Full record

ArticleAmerican journal of physiology. Cell physiology2016

Positive cross talk between protein kinase D and β-catenin in intestinal epithelial cells: impact on β-catenin nuclear localization and phosphorylation at Ser552.

Jia Wang, Liang Han, James Sinnett-Smith, Li-Li Han, Jan V Stevens, Nora Rozengurt, Steven H Young, Enrique Rozengurt

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Protein Kinase D1 (PKD1) Signaling Induces Growth-Promoting Effects in Murine Enteroids.Cellular and molecular gastroenterology and hepatology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Protein kinase D1 (PKD1) phosphorylation on SerThe Journal of biological chemistry · 2017
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jia WangDivision of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California;
Liang HanDivision of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California;
James Sinnett-SmithDivision of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California; CURE, Digestive Diseases Research Center, Los Angeles, California; Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, California.
Li-Li HanDivision of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California;
Jan V StevensDivision of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California;
Nora RozengurtCURE, Digestive Diseases Research Center, Los Angeles, California; erozengurt@mednet.ucla.edu.
Steven H YoungDivision of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California; Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, California.
Enrique RozengurtDivision of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, Los Angeles, California; CURE, Digestive Diseases Research Center, Los Angeles, California; Molecular Biology Institute, University of California at Los Angeles, Los Angeles, California; and Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, California.
University of California, Los Angeles · USVA Greater Los Angeles Healthcare System · US

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinomaP01CA163200 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PANDOL, STEPHEN J. · 2012 to 2016
$6.2M
PKD1 Signaling and Crosstalk Mechanisms in Intestinal Epithelial Cell RegulationR01DK100405 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 2014 to 2017
$1.3M
Calcium-sensing receptor signaling in the regulation of colonic epithelial cellsI01BX001473 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI ROZENGURT, JUAN ENRIQUE · 2012 to 2015
–
BLRD VA I01 BX001473NCI NIH HHS P01 CA163200NCI NIH HHS P01-CA-163200NIDDK NIH HHS P30 DK041301NIDDK NIH HHS P30 DK-41301NIDDK NIH HHS P30-DK-41301NIDDK NIH HHS R01 DK100405NIDDK NIH HHS R01-DK-100405
6 · The paper itself

Abstract

Given the fundamental role of β-catenin signaling in intestinal epithelial cell proliferation and the growth-promoting function of protein kinase D1 (PKD1) in these cells, we hypothesized that PKDs mediate cross talk with β-catenin signaling. The results presented here provide several lines of evidence supporting this hypothesis. We found that stimulation of intestinal epithelial IEC-18 cells with the G protein-coupled receptor (GPCR) agonist angiotensin II (ANG II), a potent inducer of PKD activation, promoted endogenous β-catenin nuclear localization in a time-dependent manner. A significant increase was evident within 1 h of ANG II stimulation (P< 0.01), peaked at 4 h (P< 0.001), and declined afterwards. GPCR stimulation also induced a marked increase in β-catenin-regulated genes and phosphorylation at Ser(552) in intestinal epithelial cells. Exposure to preferential inhibitors of the PKD family (CRT006610 or kb NB 142-70) or knockdown of the isoforms of the PKD family prevented the increase in β-catenin nuclear localization and phosphorylation at Ser(552) in response to ANG II. GPCR stimulation also induced the formation of a complex between PKD1 and β-catenin, as shown by coimmunoprecipitation that depended on PKD1 catalytic activation, as it was abrogated by cell treatment with PKD family inhibitors. Using transgenic mice that express elevated PKD1 protein in the intestinal epithelium, we detected a marked increase in the localization of β-catenin in the nucleus of crypt epithelial cells in the ileum of PKD1 transgenic mice, compared with nontransgenic littermates. Collectively, our results identify a novel cross talk between PKD and β-catenin in intestinal epithelial cells, both in vitro and in vivo.

Indexed as

Active Transport, Cell NucleusAnimalsbeta CateninCell LineCell NucleusFluorescent Antibody TechniqueGene Knockdown TechniquesHumansImage Processing, Computer-AssistedImmunoblottingImmunoprecipitationIntestinal MucosaMiceMice, TransgenicPhosphorylationProtein Kinase Cbeta CateninCTNNB1 protein, mouseCtnnb1 protein, ratProtein Kinase Cprotein kinase DRNA, Small InterferingSerineangiotensin IICRT006610G protein-coupled receptorsIEC-18 cellskb NB 142-70PKAPKD1 transgenic micePKD family inhibitors

Identifiers

PMID26739494
PMCPMC4824155
OpenAlexW2261961783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.